Market Research Logo

Switzerland Pharmaceuticals and Healthcare Report Q3 2015

97 Pages BMI Research July 15, 2015 SKU: BMI5630983

Switzerland Pharmaceuticals and Healthcare Report Q3 2015

BMI View: The preference for patented drugs over low-value generic medicines by patients and prescribersin Switzerland will drive the government to continue to enforce measures that restrict growth in innovativemedicine sales - particularly as the ageing population will boost the demand for long-term medicines. Thiswill include price cuts on patented medicines as well as a push towards the greater promotion of lowervaluegeneric medicines.

Headline Expenditure Projections

Pharmaceuticals: CHF7.02bn (USD7.67bn) in 2014 to CHF6.97bn (USD7.16bn) in 2015; -0.74% inlocal currency terms and -6.6% in US dollar terms.

Healthcare: CHF70.76bn (USD77.32bn) in 2014 to CHF72.58bn (USD74.62bn) in 2015; +2.6% growthin local currency terms and -3.5% in US dollar terms.

Show Full Description


Show Table of Contents



Switzerland Pharmaceuticals and Healthcare Report Q3 2015

BMI Research
July 15, 2015

Pricing & Delivery

Report with 3 quarterly updates
$1,295
Report with 3 quarterly updates - 3 User License
$1,945
Report with 3 quarterly updates - 5 User License
$2,500
Report with 3 quarterly updates - Departmental/Site License
$2,995
Global Site License Fulfilled by Publisher
$6,995

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report